Your browser doesn't support javascript.
loading
Native SEC and Reversed-Phase LC-MS Reveal Impact of Fab Glycosylation of Anti-SARS-COV-2 Antibodies on Binding to the Receptor Binding Domain.
Woodall, Daniel W; Thomson, Christy A; Dillon, Thomas M; McAuley, Arnold; Green, Lydia B; Foltz, Ian N; Bondarenko, Pavel V.
Afiliación
  • Woodall DW; Attribute Sciences, Process Development, Amgen Inc., Thousand Oaks, California 91320, United States.
  • Thomson CA; Discovery Protein Science, Amgen Research, Amgen Inc., Burnaby, BC V5A1 V7, Canada.
  • Dillon TM; Attribute Sciences, Process Development, Amgen Inc., Thousand Oaks, California 91320, United States.
  • McAuley A; Drug Product Technologies, Process Development, Amgen Inc., Thousand Oaks, California 91320, United States.
  • Green LB; Drug Product Technologies, Process Development, Amgen Inc., Thousand Oaks, California 91320, United States.
  • Foltz IN; Biologics Discovery, Amgen Research, Amgen Inc., Burnaby, BC V5A1 V7, Canada.
  • Bondarenko PV; Biologics Discovery, Amgen Research, Amgen Inc., Burnaby, BC V5A1 V7, Canada.
Anal Chem ; 95(42): 15477-15485, 2023 10 24.
Article en En | MEDLINE | ID: mdl-37812809
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Anal Chem Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Anal Chem Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos